Dr. Noonan is an expert in the translation of early stage life science technologies into development stage, often venture-‐backed, companies. Dr. Noonan is currently a Venture Partner at Lightstone Ventures; a U.S. venture fund dedicated to the creation of technology-‐rich companies in the biopharmaceutical, medical device, in vitro diagnostic and research product arenas. He will shortly take up the role of Managing Director of Lightstone Ventures, Singapore; a new fund, created with Temasek, to translate life science technologies originating in Singapore into development-‐stage companies. From 2002 – 2015 Dr. Noonan was Sr. Partner and Head of the European Life Sciences Practice at L.E.K. Consulting LLP; a well-established, global management consultancy focused on issues of commercial relevance to established and development stage companies. Dr. Noonan came to L.E.K. from Booz-‐Allen & Hamilton where he was a Partner and Head of its European Pharmaceuticals Practice. In 1992 Dr. Noonan established the European subsidiary of The Wilkerson Group Ltd.; a boutique strategic consultancy dedicated to providing strategic advice to life science companies in the U.S., Western Europe and Asia Pacific. Prior to becoming a consultant Dr. Noonan was Sr. Vice President, Corporate Development at CooperTechnicon; the second largest in vitro diagnostics company in the world and before that Director of Advanced R&D at BBL Microbiology Systems; a division of Becton Dickinson. Dr. Noonan began his commercial career as one of the founding scientists of Bethesda Research Labs; one of the earliest biotechnology company. Dr. Noonan’s academic career included eight years as a tenured professor at the University of Florida School of Medicine where he was the author of over 50 scientific publications on the role of the cell membrane in the regulation of cell growth. Dr. Noonan has Ph.D. in Biochemistry from Princeton University.